General Information
| Gene ID | 5329 |
|---|---|
| Gene Symbol | PLAUR |
| Gene Name | plasminogen activator, urokinase receptor |
| Gene Type | protein-coding |
| Cytoband | 19q13 |
| Ensembl ID | ENSG00000011422 |
| #miR regulators | 5 |
| Omim ID | 173391 |
| Gene ontology |
GO:0007596: blood coagulation GO:0007165: signal transduction GO:0006501: C-terminal protein lipidation GO:0006928: cellular component movement GO:0006935: chemotaxis GO:0016255: attachment of GPI anchor to protein GO:0030162: regulation of proteolysis GO:0042730: fibrinolysis GO:0043687: post-translational protein modification GO:0044267: cellular protein metabolic process GO:0005886: plasma membrane GO:0016021: integral to membrane GO:0019898: extrinsic to membrane GO:0005576: extracellular region GO:0005887: integral to plasma membrane GO:0005788: endoplasmic reticulum lumen GO:0005789: endoplasmic reticulum membrane GO:0009986: cell surface GO:0031225: anchored to membrane GO:0005515: protein binding GO:0004872: receptor activity GO:0019899: enzyme binding GO:0030377: U-plasminogen activator receptor activity |
| KEGG pathways |
4610: Complement and coagulation cascades |
| PMID | Title | Tumor | Value |
|---|---|---|---|
| 8391387 | Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. | no | no |
| 10086509 | Protease expression in dedifferentiated parosteal osteosarcoma. | yes | no |
| 10807968 | Effect of hyperthermia on the viability and the fibrinolytic potential of human cancer cell lines. | no | no |
| 15095405 | IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma. | no | no |
| 16008557 | Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells. | yes | no |
| 17980359 | Icariside II from Epimedium koreanum inhibits hypoxia-inducible factor-1alpha in human osteosarcoma cells. | no | no |
| 23201449 | Phyllanthus urinaria suppresses human osteosarcoma cell invasion and migration by transcriptionally inhibiting u-PA via ERK and Akt signaling pathways. | no | no |
| title | all | all |
